News Links
Popular Press from October 7, 2015
The End Isn’t Near. 89-year-old diabetes patient thrives on insulin for more than 8 decades. New technology helps manage diabetes. McCandless teen with diabetes is honored. For Lowell field hockey trio, diabetes fuels a special bond. Find Out What It’s Like to Run Marathons With Type 1 Diabetes. Rapid City woman completes Ironman, in spite of diabetes. Experimental device could be life-changing for those with Type 1 diabetes. Q and A with Miss Wales 2016 finalist and type 1 diabetic Ruby Parfitt. Hypo unawareness affects cognitive function in type 1 diabetes, study finds. Insulin-producing cells offer hope for people with […]
Read MoreLegislative and Policy News from October 7, 2015
Mother: ‘I would rather my daughter dies at home than give her insulin’. See also Diabetic girl must be given insulin despite mother’s stance.
Read MoreCeliac News from October 7, 2015
The Role of Gluten in Celiac Disease and Type 1 Diabetes. Free full text available in HTML and PDF via link. Prevalence of celiac disease in adult type 1 patients with diabetes. Free full text available in HTML and PDF formats. Vitamin and mineral deficiency in children newly diagnosed with celiac disease. General Mills issues voluntary Class I recall of Cheerios and Honey Nut Cheerios cereal produced at its Lodi, California location on certain dates. Oats and the Pitfalls of Gluten-Free Labeling. Gluten-Free Game Changer: The Nima Sensor.
Read MoreDaily Care News from October 7, 2015
Recent advances in type 1 diabetes. Free full text available in PDF format. Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis. Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial. Use of communication technologies by people with type 1 diabetes in the social networking era. A chance for improvement. Grandparent Education Through Simulation-Diabetes. Reproductive knowledge and use of contraception among women with diabetes. Evaluation of Immunogenicity of LY2963016 Insulin Glargine Compared with Lantus® Insulin Glargine in Patients with Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus.
Read MoreResearch News From October 7, 2015
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes. Development of a Smartphone Application to Capture Carbohydrate, Lipid, and Protein Contents of Daily Food: Need for Integration in Artificial Pancreas for Patients With Type 1 Diabetes? Type 1 diabetes prevention: Insulin vaccine undergoes second trial.
Read MoreResearch News From September 30, 2015
Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report. Free full text available in PDF format. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Free full text available in PDF format. American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiom. Alternate Approaches for Pediatric Type 1 Diabetes Drug Development and Potential Regulatory Approval: A Perspective. Free full text available in PDF format. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study. Free full text available in […]
Read MoreResearch News From September 23, 2015
Home Use of an Artificial Beta Cell in Type 1 Diabetes. Free full text available in PDF format. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System’s Fuzzy Logic Controller. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents. Efficacy and safety of canagliflozin: results of an 18-week phase 2 study in patients with type 1 diabetes. See also Invokana lowers […]
Read MoreResearch News From September 18, 2015
Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration and selected gut bacteria. Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial.
Read MoreResearch News From September 9, 2015
Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System. Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels. After 6 years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal level. Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes. Free full text available in HTML and PDF formats. Risk factors associated with the development of retinopathy 10 yr after the diagnosis of juvenile-onset type 1 diabetes in Taiwan: a cohort study from the CGJDES. […]
Read More